MLAB
Mesa Laboratories Inc
133.00$
-1.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 18.5% | 16.0% | 24.5% | 24.2% | 23.8% | 25.4% | 23.7% | 22.5% | 22.6% | 24.3% | 24.8% | 24.5% | |
| 5.6% | 3.8% | 6.3% | 6.5% | 5.4% | 7.1% | 6.3% | 4.9% | 4.7% | 6.7% | 6.3% | 7.3% | |
| 5.6% | 3.8% | 6.3% | 6.5% | 5.4% | 7.1% | 6.3% | 4.9% | 4.7% | 6.7% | 6.3% | 7.3% | |
| 5.7% | 4.9% | 8.7% | 8.1% | 8.9% | 8.8% | 9.7% | 9.0% | 9.3% | 9.3% | 10.3% | 8.2% | |
| 5.2% | 4.8% | 7.3% | 7.2% | 6.5% | 6.4% | 5.9% | 6.5% | 6.4% | 6.1% | 6.2% | 6.5% | |
| 44.5% | 46.7% | 40.3% | 40.8% | 40.5% | 40.5% | 41.9% | 43.2% | 43.8% | 43.5% | 43.7% | 44.4% | |
| 31.0% | 31.4% | 25.5% | 24.9% | 24.0% | 22.5% | 22.4% | 22.4% | 21.7% | 20.6% | 19.5% | 18.7% | |
| 39.1% | 45.7% | 67.5% | 65.8% | 64.4% | 64.5% | 63.1% | 60.4% | 58.5% | 57.1% | 56.5% | 55.0% | |
| 6.2% | 6.0% | 9.9% | 12.5% | 33.7% | 35.7% | 37.8% | 34.3% | 11.2% | 12.5% | 14.5% | 11.8% | |
| 0.4% | 0.4% | 0.7% | 1.5% | 23.0% | 23.9% | 24.1% | 24.2% | 2.0% | 2.1% | 2.2% | 2.0% | |
| 0.8% | 0.6% | 1.4% | 1.3% | 1.3% | 0.9% | 1.3% | 1.4% | 1.2% | 1.2% | 1.2% | 1.8% | |
| 26.8% | 31.4% | 49.6% | 47.3% | 22.9% | 21.7% | 17.7% | 18.3% | 39.5% | 37.0% | 34.1% | 32.7% | |
| 60.9% | 54.3% | 32.5% | 34.2% | 35.6% | 35.5% | 36.9% | 39.6% | 41.5% | 42.9% | 43.5% | 45.0% | |
| 11.1% | 9.7% | -41.1% | -41.1% | -39.3% | -41.4% | -43.6% | -42.5% | -42.6% | -41.6% | -43.4% | -43.8% | |
| 0.8% | 0.7% | 1.2% | 1.2% | 1.2% | 1.2% | 1.3% | 1.3% | 1.3% | 1.3% | 1.3% | 1.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.